Anti-amyloid antibodies (lecanemab, donanemab) are monoclonal antibodies that bind and clear amyloid-beta, the protein that aggregates into plaques in Alzheimers disease, and they are the clearest disease-modifying drugs to reach the clinic
*Other products available...just ask
R., Tharakan, M., George, L., & Koshy, S
Studies have suggested that increased susceptibility to KBD in selenium-deficient populations might result from a reduced antioxidant protection associated with polymorphisms in GPX genes (60, 61), but polymorphisms in other genes have also been implicated (62)
This is crucial for maintaining the sterility and safety of the solution over its refrigerated lifespan
Drawing technique: Swab the peptide vial top and allow it to dry